Target intelligence / Profile preview

Synaptic Ras GTPase-activating protein 1 (SYNGAP1)

Target
SYNGAP1
Molecular classification
Enzyme (GTPase activating protein), Postsynaptic density (PSD) scaffold-associated protein, Member of the N-methyl-D-aspartate receptor complex
01

Overview

Synaptic Ras GTPase–activating protein 1 (SYNGAP1) is a major component of the postsynaptic density at excitatory synapses in the brain. It functions as a Ras/Rap GTPase activating enzyme, negatively regulating these small G-proteins, which are critical for intracellular signaling cascades involved in synapse formation, plasticity, and cognitive development. SYNGAP1 is essential for normal cognition, learning, memory, and proper maturation of dendritic spines. It acts as an inhibitory regulator within NMDA receptor complexes to control AMPA receptor insertion into the membrane—a key process underlying synaptic strength adjustments during learning. Mutations or loss-of-function variants in SYNGAP1 cause severe neurodevelopmental disorders including intellectual disability, epilepsy, autism spectrum disorder, and sensory processing abnormalities. The gene produces multiple isoforms through alternative splicing that can have distinct effects on neuronal signaling; knockout models demonstrate its necessity for survival and normal brain circuit formation[1][2][4].

Other names
SynGAPRASA5 (Ras GTPase-activating protein 5)Synaptic Ras-GAP 1
02

Biological functions

Regulation of synaptic plasticityNegative regulation of Ras and Rap signaling pathwaysControl of AMPA receptor trafficking to the postsynaptic membraneModulation of dendritic spine development and maturationRegulation of neuronal homeostasis and excitatory synapse function
03

Disease associations

Intellectual disability (including autosomal dominant forms)EpilepsyAutism spectrum disorderSensory processing deficitsTumor suppressor function in some contexts

Beyond the preview

Go deeper on Synaptic Ras GTPase-activating protein 1 (SYNGAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic Ras GTPase-activating protein 1 (SYNGAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call